Periodic Reporting for period 1 - ISOS (ISOS-Implantable Ecosystems of Genetically Modified Bacteria for the Personalized Treatment of Patients with Chronic Diseases)

ISOS aims to develop the first biomedical product for in-situ fabrication and sustained delivery of therapeutics using probiotic genetically engineered bacteria (GEB) within a biomaterial-based bioreactor for chronic disease treatment.Encapsulated GEBs produce drugs "on...